CELEX: 62020TB0496
Language: en
Date: 2021-04-08 00:00:00
Title: Case T-496/20: Order of the General Court of 8 April 2021 — CRII-GEN and Others v Commission (Action for annulment — Plant protection products — Active substance glyphosate — Request for review for the purpose of withdrawing or amending the approval — Article 21 of Regulation (EC) No 1107/2009 — Rejection — Act not open to challenge)

14.6.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 228/29
            
         
      Order of the General Court of 8 April 2021 — CRII-GEN and Others v Commission
      (Case T-496/20) (1)
      
      (Action for annulment - Plant protection products - Active substance glyphosate - Request for review for the purpose of withdrawing or amending the approval - Article 21 of Regulation (EC) No 1107/2009 - Rejection - Act not open to challenge)
      (2021/C 228/40)
      Language of the case: French
      
         Parties
      
      
         Applicants: Comité de recherche et d’information indépendantes sur le génie génétique (CRII-GEN) (Paris, France), and the 6 other applicants whose names are listed in the annex to the order (represented by: C. Lepage, lawyer)
      
         Defendant: European Commission (represented by: X. Lewis, G. Gattinara, I. Nagalis and G. Koleva, acting as Agents)
      
         Re:
      
      Application under Article 263 TFEU for annulment of the Commission’s decision of 17 June 2020 rejecting the applicants’ request, made under Article 21 of Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ 2009 L 309, p. 1), to withdraw or amend the approval of active substance glyphosate.
      
         Operative part of the order
      
      
                  1.
               
               
                  The action is dismissed.
               
            
                  2.
               
               
                  There is no longer any need to adjudicate on the application for leave to intervene submitted by Bayer Agriculture BV.
               
            
                  3.
               
               
                  The Comité de recherche et d’information indépendantes sur le génie génétique (CRII-GEN) and the other applicants whose names are listed in the annex shall pay the costs, with the exception of those incurred by Bayer Agriculture relating to its application for leave to intervene.
               
            
                  4.
               
               
                  Bayer Agriculture shall bear its own costs relating to the application for leave to intervene.
               
            
         (1)  OJ C 329, 5.10.2020.